The human microbiome has fascinated scientists for decades. With the advances in sequencing techniques, it has finally become possible for researchers to start putting the pieces of the puzzle together. An entire industry dedicated to Microbiome Therapeutics is slowly taking shape, the sole purpose of which is to identify treatments for ailments such as cancer and autism based on the minor alteration of the body microbiome. Although the human microbiome consists of bacterial, fungal and viral species, currently the industry is focused on the bacterial part of the microbiome.

Download Whitepaper

PDF not available.

    Contact Us